John W. Titus

John Titus has extensive experience in public and private offerings of debt and equity securities, proxy contests and tender offers, corporate mergers and acquisitions, and corporate financing transactions for businesses in a variety of industries with a particular emphasis on healthcare services. He frequently functions as general counsel to his clients, advising on all aspects of corporate, securities and business law matters. He advises boards of directors and executive management of the firm’s publicly-traded clients on corporate governance matters, including compliance with requirements imposed by Sarbanes-Oxley, TARP and Dodd-Frank legislation, and general fiduciary duties in the context of mergers, acquisitions and recapitalizations. His corporate finance experience includes handling public and private offerings of equity and debt securities, proxy contests, mergers and reporting obligations of publicly traded companies; representing clients in conducting syndications of investments in healthcare providers such as surgery centers, imaging centers, cancer care centers and hospitals. He has served as Vice Chairman of the firm’s Corporate and Securities Practice Group and currently serves as Chairman of the firm’s Public Companies Team.

John is the Co-Author of "Sarbanes - Oxley: What it Means for Private Companies and ESOPs," The Journal of Employee Ownership Law and Finance, vol. 16, No. 1, Winter 2004.

He has lectured and instructed on Securities and Exchange Commission reporting requirements and the recently-enacted Dodd-Frank Wall Street Reform and Consumer Protection Act and has authored a number of articles on corporate and securities law matters. He is a former member of the New Member Ambassadors Committee of the Nashville Area Chamber of Commerce. He is an active member of the Tennessee Business Corporation Act subcommittee of the Tennessee Bar Association Business Entity Study Committee. John is a member of the Nashville, Tennessee, and American Bar Associations. He is a member of the Board of Directors for the Nashville Capital Network and a member of the Executive Committee of the Business Law Section of the Tennessee Bar Association. He was selected as "Best of Bar" by the Nashville Business Journal in 2011. John is listed in The Best Lawyers in America® 2009 and 2010 for corporate law and Chambers USA: America's Leading Lawyers for Business 2009 and 2010 for corporate/M&A.

John’s recent healthcare work includes:

• Represented publicly-traded, correctional healthcare services company in connection with corporate and securities law matters and in connection with $250 million merger transaction with the company’s largest competitor to create the largest service provider in the U.S. market
• Represents private equity-backed, oncology healthcare services company in connection with corporate finance and mergers and acquisitions matters, including $150 million recapitalization transaction
• Represented private equity-backed, ambulatory surgery center company in connection with corporate and securities law matters, including $100 million private equity funding, multiple physician-syndications, and sale of company to another private-equity backed provider
• Represents private equity-backed, diagnostic imaging company in connection with corporate mergers and acquisitions and corporate and commercial finance matters
• Represents Nashville-based company developing dedicated allergy, asthma and sinus treatment centers across the country in connection with corporate mergers and acquisitions and in connection with venture capital funding